MPG.eBooks - Search Results - "Multiple Sclerosis"

Cover Image

1

CADTH Canadian Drug Expert Committee recommendation: Cladribine (Mavenclad -- EMD Serono) : indication: relapsing-remitting multiple sclerosis

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Multiple Sclerosis, Relapsing-Remitting / drug therapy...”

Cover Image

2

CADTH Canadian Drug Expert Committee recommendation: Daclizumab (Zinbryta -- Biogen Canada Inc.) : indication: relapsing-remitting multiple sclerosis

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Multiple Sclerosis, Relapsing-Remitting / drug therapy...”

Cover Image

3

CADTH Canadian Drug Expert Committee recommendation: Ocrelizumab (Ocrevus -- Hoffmann-La Roche Limited) : indication : treatment of adult patients with relapsing-remitting multiple...

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Multiple Sclerosis, Relapsing-Remitting / drug therapy...”

Cover Image

4

CADTH Canadian Drug Expert Committee recommendation: Ocrelizumab (Ocrevus -- Hoffmann-La Roche Limited) : indication : treatment of adult patients with relapsing-remitting multiple...

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Multiple Sclerosis, Relapsing-Remitting / drug therapy...”

Cover Image

5

CADTH Canadian Drug Expert Committee recommendation: Ocrelizumab (Ocrevus-Hoffmann-La Roche Limited) : indication : management of adult patients with early primary progressive mult...

Published 2018

CADTH

Subjects: “...Multiple Sclerosis / drug therapy...”